Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific : Sets $3 Billion Share Buyback Program

09/23/2021 | 04:13pm EDT


ę MT Newswires 2021
All news about THERMO FISHER SCIENTIFIC
06:29aCitigroup Adjusts Thermo Fisher Scientific's Price Target to $715 From $700, Reiterates..
MT
10/27Today on Wall Street: It’s a numbers game
10/27Thinking about trading options or stock in Thermo Fisher Scientific, Bristol-Myers Squi..
PR
10/27Health Care Stocks Mixed Premarket Wednesday
MT
10/27Equities Point to Mixed Open With Futures Little Changed in US Pre-Bell Trading; Asia, ..
MT
10/27Wall Street Edges Back Pre-Bell; Futures Flat, Europe Off, Asia Lower
MT
10/27Thermo Fisher Scientific Fiscal Q3 Adjusted EPS, Revenue Gain; Company Lifts FY Outlook
MT
10/27Thermo Fisher Scientific Reports Third Quarter 2021 Results - Form 8-K
PU
10/27THERMO FISHER SCIENTIFIC INC. : Results of Operations and Financial Condition, Financial S..
AQ
10/27NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
DJ
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2021 37 136 M - -
Net income 2021 7 614 M - -
Net Debt 2021 26 262 M - -
P/E ratio 2021 31,9x
Yield 2021 0,16%
Capitalization 241 B 241 B -
EV / Sales 2021 7,19x
EV / Sales 2022 6,60x
Nbr of Employees 80 000
Free-Float 89,6%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | TMO | US8835561023 | MarketScreener
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 612,29 $
Average target price 659,48 $
Spread / Average Target 7,71%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors